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Adrenomedullin (AM) and proadrenomedullin N-terminal 20
peptide (PAMP) are secretory hormones, but it is not unusual
to find them in intracellular compartments. Using yeast-2 hy-
brid technology, we found interactions between AM and sev-
eral microtubule-associated proteins (MAPs), and between
PAMP and tubulin. Expression of fluorescent-tagged AM and
PAMP as well as immunofluorescence for the native peptides
showed a complete decoration of the microtubules and colo-
calization with other MAPs. PAMP, but not AM, bound to tu-
bulin in vitro and destabilized tubulin polymerization. Down-
regulation of the gene coding for both AM and PAMP through
small interfering RNA technology resulted in morphological
changes, microtubule stabilization, increase in posttransla-
tional modifications of tubulin such as acetylation and dety-
rosination, reduction in cell motility, and partial arrest at the
G2 phase of the cell cycle, when compared with cells trans-
fected with the same vector carrying a scrambled sequence.
These results show that PAMP is a novel MAP, whereas AM
maybeexertingmore subtle effects in regulating cytoskeleton
function. (Endocrinology 149: 2888–2898, 2008)
THE PROADRENOMEDULLIN (proAM) precursor mol-ecule is the source of two biologically active peptides,
adrenomedullin (AM), which is a 52-amino acid long peptide
hormone that contains an intramolecular disulfide bond, and
proadrenomedullin N-terminal 20 peptide (PAMP). Both
molecules are amidated at their carboxy terminus, and are
expressed by a wide variety of tissues and cell types through-
out vertebrate species, in which they play a range of phys-
iological functions. These regulatory roles include vasodila-
tation, bronchodilatation, renal homeostasis, hormonal
regulation, neurotransmission, antimicrobial activity,
growth, and angiogenesis, among others (for a complete
review, see Ref. 1). In addition, they are involved in the
physiopathology of several relevant diseases such as hyper-
tension, cardiovascular diseases, cancer, and diabetes (2, 3).
The intracellular distribution of AM and PAMP in classical
endocrine organs follows the expected pattern for a secretory
peptide, accumulating in the lumen of the secretory granules,
as shown in the F cells of the endocrine pancreas (4, 5), the
anterior pituitary (6), the adrenals (7), cells of the diffuse
endocrine system in the gut (8), the juxtaglomerular complex
of the kidney (9), or the glomus cells of the carotid body (10).
In contrast, the few ultrastructural studies performed in
nonendocrine organs show a different distribution. For in-
stance, most of the deposits associated with AM immuno-
reactivity encountered in neurons are found in the proximity
of the cytoskeleton or in the cytoplasmic side of mitochon-
drial and nuclear membranes, rather than in the synaptic
vesicles (11). In ciliated cells of the bronchial epithelium, AM
immunoreactivity accumulates in the apical cytoplasm in
close proximity to the ciliary roots (12). This localization may
represent an active secretion to the lumen through a non-
regulated secretory pathway (12), but it could also suggest a
specific intracellular function. It is also interesting that in
specific areas of the rat brain (olfactory bulb and caudate
putamen), AM immunoreactivity is restricted to the cell nu-
cleus, whereas in the rest of the brain, AM is always found
in the cytoplasm (11), thus revealing a tightly regulated sub-
cellular distribution.
Several classical peptide hormones such as insulin, epi-
dermal growth factor, platelet derived growth factor, nerve
growth factor, and prolactin, among others, play intracellular
roles as well (13). Given their wide range of activities, it
would not be surprising if AM and PAMP were another
example of this growing set of intracellularly active hor-
mones. To explore this possibility, we decided to perform a
yeast-2 hybrid screening using AM or PAMP as the bait, so
as to identify molecular partners for these molecules and
determine potential intracellular functions of these peptides.
This analysis identified several microtubule-associated pro-
teins (MAPs) as binding partners of AM, and tubulin as a
binding partner for PAMP. Here, we present experimental
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evidence showing that AM and PAMP decorate microtu-
bules in cells from different origins. In addition, down-reg-
ulation of proAM expression by small interfering RNA
(siRNA) knockdown or gene knockout technology has a pro-
found effect on cytoskeleton morphology, cell cycle, and
migration capabilities in the affected cells.
Materials and Methods
Yeast-2 hybrid
The reading frame for the human 52-amino acid AM peptide followed
by the amidation motif was cloned into the NcoI-BamHI sites of the bait
vector pGBKT7 (Clontech, Palo Alto, CA) using as primers: sense 5’-GCC
ATG GAG TAC CGC CAG AGC ATG AAC AAC-3’ and antisense
5’-GGA TCC GGA GCG CCG GCG CCG GCG GCC GTA GCC CTG-3’.
The reading frame for human PAMP, containing the amidation motif,
was cloned into the KpnI-SmaI sites of the bait vector pLexA-N (Dual-
systems, Zu¨rich, Switzerland) using as primers: sense GGT ACC GCT
CGG TTG GAT GTC GCG TCG and antisense CCC GGG CGC CTC TTC
CCA CGA CTC AGA GC. Cloning fidelity was ensured by sequencing.
The bait plasmid was transfected into yeast strain AH109 containing an
adult human brain library using the Yeastmaker Transformation system
(BD Biosciences, San Jose, CA, Clontech), and interacting clones iden-
tified by the ability to grow on minimal sd agar medium lacking adenine,
histidine, leucine, and tryptophan (quadruple synthetic dropout selec-
tion plates). Prey plasmids were recovered and retransformed into
AH109 with the bait or GAL4 DNA binding domain alone to verify
interactions by -galactosidase filter lift assays and by -galactosidase
liquid assays. The identity of interacting clones was determined by DNA
sequencing.
Generation of vectors expressing AM, PAMP, and
cytoskeleton-associated protein 1 (CKAP1) fused to
fluorescent proteins
The reading frame for human AM was inserted into the EcoRI-BamHI
site of the red fluorescent protein carrying vector pHcRed1-C1 (Clon-
tech) using as primers: sense 5’-GAA TTC TTA CCG CCA GAG CAT
GAA CAA C-3’ and antisense 5’-GGA TCC GGA GCG CCG GCG CCG
GCG GCC GTA GCC CTG-3’. This plasmid was named pRed-AM. The
reading frame for human PAMP was inserted into the EcoRI-BamHI site
of the green fluorescent protein carrying vector pEGFP-C1 (Clontech)
using as primers: sense 5’-GAA TTC TGC TCG GTT GGA TGT CGC
GTC G-3’ and antisense 5’-GGA TCC CCT CTT CCC ACG ACT CAG
AGC-3’. This vector was named pGreen-PAMP. At the same time, the
reading frame for human CKAP1 was inserted into the green fluorescent
protein carrying vector pEGFP-C3 (Clontech) with primers: sense 5’-
GAA TTC TAC GAG GAG GAG CGG GCT C-3’ and antisense 5’-GGA
TCC TCA TAT CTC GTC CAA CCC-3’. This vector was named pGreen-
CKAP. All clones were analyzed by sequencing.
Microtubule binding protein spin-down assay
To investigate whether AM and PAMP are microtubule binding pro-
teins (MAPs), synthetic human AM or PAMP (Phoenix Pharmaceuticals,
Inc., Mountain View, CA) at a final concentration of 2.0 mm was incu-
bated with taxol-stabilized microtubules for 30 min at room tempera-
ture, following the indications of the Microtubule Binding Protein Spin-
Down Assay Kit (Cytoskeleton, Denver, CO). Microtubules were
pelleted by centrifugation at 100,000 g for 40 min at room temperature.
Aliquots of both the pellets and supernatants were mixed with loading
buffer and analyzed by Western blotting with the AM or PAMP antibody
as described below. The immunoreactive bands were quantified by
densitometry.
Microtubule polymerization assay
The effects of AM and PAMP on tubulin polymerization were in-
vestigated using the high-throughput screening-tubulin polymerization
assay kit (Cytoskeleton). Briefly, bovine brain tubulin (400 g/sample)
in the presence and absence of synthetic human AM (1 m to 2 mm),
synthetic human PAMP (1 nm to 1 m), or 200 m paclitaxel (Cytoskel-
eton) was incubated in PEM buffer [80 mm PIPES, 1 mm EGTA, 1 mm
MgCl2 (pH 6.8)] containing 1.0 mmGTP (G-PEM) at 37 C, and the degree
of polymerization over time was measured in a spectrophotometer (Flu-
ostar Optima; BMG Labtechnologies, Offenburg, Germany) at 340 nm.
Construction of siRNA vectors against proAM
Five target sequences within the human proAM mRNA sequence
(GenBank NM_01124) were chosen based upon position in the mRNA
sequence as well as GC content within the 40–60% range. They were
identified with siRNA target finder software available on-line at
www.ambion.com, according to the selection criteria published at www.
ambion.com/techlib/tb/tb_506.html. Primer pairs were made and the
sequences amplified using Ambion’s Silencer Express siRNA Expression
Cassette Kit (Ambion, Inc., Austin, TX). The primer pairs introduce an
RNA polymerase initiation site and 5 EcoRI and 3 HindIII restriction
sites for direct cloning into the pSEC vectors. The five amplicons were
transcribed into RNA in vitro and tested by transient transfection of
Chinese hamster ovary (CHO) cells cotransfected with pFLAG-AM (14)
followed by RT-PCR. The two sequences showing a higher degree of
silencing were inserted into the human U6 promoter-driven pSEC vector
(Ambion) by EcoRI and HindIII digestion and ligation. The target se-
quences for these siRNAs are AAG GAA TAG TCG CGC AAG CAT (this
vector was called pSEC-AM735), and AAG CTG GCA CAC CAG ATC
TAC (pSEC-AM511). Vectors containing scrambled versions of the same
sequences were used as controls. The sequences were AAG ACG GAC
GGC AAG TCC TAC (pSEC-AM735scr) and AAG GCG CCA CTC GCC
CAA ATA AT (pSEC-AM511scr).
Cell lines, transfections, and confocal microscopy
Cell lines COS7 (monkey kidney), A549 (human lung adenocarci-
noma), CHO, and PC12 (rat pheochromocytoma) were obtained from
the American Type Culture Collection (Manassas, VA). The human
neuroblastoma cell lines BE2 and KCNR were a generous gift from Dr.
Carol Thiele (National Cancer Institute, Bethesda, MD). The rat hypo-
thalamic immortalized cell line H32 was a generous gift from Dr. Greti
Aguilera (National Institute of Child Health and Human Development,
Bethesda, MD) (15). COS7 and A549 cells were transfected with the
indicated plasmids using FuGENE 6 transfection reagent (Roche, Basel,
Switzerland). Stable transfectants were selected by adding to the me-
dium 800 g/ml Geneticin (Invitrogen, Carlsbad, CA), and the levels of
AM mRNA and protein were characterized by real-time PCR and West-
ern blotting, respectively, as reported (10, 16).
Transfected cells were seeded into glass slides and eventually fixed
in 10% formalin for 10 min. Cells destined for immunocytochemical
procedures were permeabilized with 0.1% Triton X-100, blocked with 3%
normal goat serum, and exposed to primary antibodies overnight at 4
C. Primary antibodies include mouse monoclonal anti- tubulin (clone
DM1A; Sigma-Aldrich, St. Louis, MO) and rabbit anti-de-tyrosinated
-tubulin (glu-tubulin; CHEMICON International, Inc., Temecula, CA).
The following day, a mixture of Bodipy-phallacidin (Molecular Probes,
Inc., Eugene, OR) and Texas-red goat antirabbit or antimouse IgGs
(Molecular Probes) was applied to the cells for 1 h, followed by 4,6-
diamidino-2-phenylindole (DAPI) (Molecular Probes) as a nuclear coun-
terstain. Unmodified cells were stained with antibodies against -tu-
bulin (as previously described) and rabbit anti-AM or anti-PAMP
antibodies prepared in house (5, 9). Slides were analyzed with a Zeiss
Laser Scanning Microscope 510 (Carl Zeiss, Inc., Thornwood, NY),
equipped with four lasers. Microtubule depolymerization was induced
by exposure to cold temperature (4 C) for 30 min or by addition of 1 
105 m nocodazole (Sigma-Aldrich).
Heterozygote AM-null mice (Ferna´ndez, A. P., J. Serrano, L. Tessa-
rollo, F. Cuttitta, and A. Martı´nez, manuscript in preparation) were
crossed, and pregnant females were killed at d 12. Mouse embryo fi-
broblasts were obtained by disaggregating embryo tissue in DMEM
medium containing 10% fetal bovine serum. After several passages,
these cells were immortalized by exposure to the large T-antigen con-
taining vector, pRSV-T. Cell lines were genotyped by PCR, and the
phenotype was confirmed by RIA of the conditioned medium for AM.
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Western blotting
Transfected COS7 cells were homogenized in lysis buffer [50 mm
Tris/HCl (pH 7.5), 150 mm NaCl, 1% Triton X-100, 1% deoxycholate,
0.1% (wt/vol) NaN3, 1 mm EGTA, 0.4 mm EDTA, 1 mm phenylmeth-
ylsulfonylfluoride, 0.2 mm Na3VO4, and protease inhibitor cocktail] and
sonicated. Lysates were clarified by centrifugation at 15,000  g for 10
min, and protein concentration was estimated in the supernatant using
the bicinchoninic acid protein assay kit from Pierce (Rockford, IL). Equal
amounts of total protein (25 g) were loaded into 4–12% NuPage Bis-
Tris gels (Invitrogen), electrophoresed in 2-(N-morpholino) ethanesul-
fonic acid buffer, and transferred to nitrocellulose membranes (Invitro-
gen). Detection of tubulin immunoreactivity was accomplished with
antibodies against acetylated tubulin (Sigma-Aldrich), glu-tubulin, and
-tubulin (Sigma-Aldrich). A monoclonal antibody against glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) (CHEMICON) was used as
a loading control. The enhanced chemiluminescence Advance Western
Blotting Detection Kit from Amersham Biosciences, Inc. (Piscataway, NJ)
was used to develop the blots.
RIA
The concentrations of AM found in conditioned media of test samples
were determined using a commercially available RIA kit (Phoenix Phar-
maceuticals). Samples (1 ml) were initially diluted in an equal volume
of 0.1% alkali-treated casein in PBS (pH 7.4), and applied to prewashed
reverse-phase Sep-Pak C-18 cartridges (Waters Corp., Milford, MA). The
peptide fraction was eluted from the C18 matrix with 3 ml 80% isopro-
panol containing 0.125 n HCl and freeze-dried overnight. AM levels
found in lyophilized extracts were then determined by RIA following the
manufacturer’s instructions.
Motility assays. Vascular endothelial growth factor (0.1 nm) was placed
at the bottom of a ChemoTx chamber (NeuroProbe Inc., Gaithersburg,
MD) as a chemotactic factor (17). The intermediate membrane was
coated with 10 g/ml fibronectin, and in the upper chamber, 5.0  105
cells were added. After a 4-h incubation at 37 C, the membrane was fixed
and stained (Protocol Hema3; Biochemical Sciences Inc., Swedesboro,
NJ). The cells trapped in the porous membrane were photographed
through a 25 microscope objective, and the number of cells per pho-
tographic field was counted.
Cell cycle analysis. Cells were trypsinized and resuspended in propidium
iodide solution (DNAcon3 kit; DakoCytomation, Carpinteria, CA) for
1 h at 4 C, following the manufacturer’s instructions. Cells were analyzed
for DNA content by flow cytometry in a Becton Dickinson FACScan
cytometer (Mansfield, MA), and cell cycle analysis was performed with
ModFit LT 1.01 software (Becton Dickinson).
Results
Yeast-2 hybrid screening
We screened for proteins that interact with full-length AM
or PAMP using the yeast-2 hybrid system. The fragments of
the human adm gene coding for the mature peptides were
cloned into the bait plasmids, and protein expression in yeast
strain AH109 was determined by Western blot analysis (data
not shown). Briefly, a pretransformed human brain match-
maker cDNA library in the MAT- yeast strain Y187 was
mated with the MAT-a yeast strain AH109 transformed with
the bait constructs. ADE2, HIS3, and LacZ reporter genes are
under the control of GAL4-dependent promoters. A func-
tional interaction between the two hybrids after the mating
process would be expected to produce Ade and His pro-
totrophs and -galactosidase activity. For AM, 14 potential
candidates were isolated from the primary screen on QDO
selection plates. These were then subjected to a second round
of screening to eliminate false positives by growing the can-
didates on QDO selection plates containing the indicator
substrate X--Gal (Fig. 1A) and by -galactosidase liquid
culture assay (Fig. 1B) to detect -galactosidase and -ga-
lactosidase activity, respectively. The cDNAs were extracted
from the 12 of 14 positive candidates that formed blue col-
onies on QDO/X--galactosidase selection plates and
showed significant -galactosidase activity, and identified
by DNA sequencing (Table 1). Several of the potential bind-
ing partners of AM thus identified had the common feature
of being MAPs. These included MAP1A (three clones), a
major component of the microtubules in mature neurons (18,
19), CKAP1, which is involved in tubulin folding (20), and
RANBP9, a Ran binding protein that has been described in
association with the centrosome (21, 22).
A similar process was performed for PAMP. From an
initial set of 21 positive clones, 16 passed all the screening
tests and were subjected to sequencing to identify the prey
proteins (Table 2). These included two clones containing
tubulin -2A, a main component of the microtubules, and
another two clones with the sequence for the kinesin heavy
chain member 2 (Kif2), a motor protein involved in spindle
assembly and axonal transport (23).
FIG. 1. Secondary screening of candidate yeast-2 hybrid colonies. A,
Potential candidates were plated onto SD/-L/-T plates to verify the pres-
ence of the bait, and prey plasmids (left panel) and replica spotting of
potential candidates from (LT) were also plated onto QDO plates (SD/-
L/-T/-A/-H) containing X--Gal indicator substrate (right panel). Blue
colonies are scored as positive candidates. White or no growth is con-
sidered to be false positives from the primary screen.One through14 are
candidate interactors. B, Quantification of -galactosidase activity of
candidate yeast colonies in liquid culture. Of the candidates, 12 (1–7, 9,
10, 12–14) produce significant -galactosidase activity. Negative (N)
control for -galactosidase activity is yeast transformedwith empty bait
and prey vectors. Positive (P) control for -galactosidase activity is yeast
transformed with p53 prey and SV40 large T-antigen bait.
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AM and PAMP are associated with microtubules in intact
cells
To investigate whether AM and PAMP are found in mi-
crotubules, an AM-red fluorescent protein fusion expression
vector was transfected into COS7 cells and the microtubules
detected with an antitubulin antibody followed by a green
fluorescent secondary IgG. Confocal images of these cells
reveal a complete overlapping of the red and green fluores-
cence (Fig. 2, A–D) showing that AM fully decorates the
microtubules. Double transfections with red-labeled AM and
green-labeled CKAP1 also showed a complete colocalization
along the length of the microtubules (Fig. 2, E–H).
To ensure that the presence of AM or PAMP in the mi-
crotubules was not an artifact of overexpressing the peptide
at levels much higher than the ones found in unadulterated
cells, several cell lines derived from brain tumors or an im-
mortalized cell line obtained from rat hypothalamus (H32)
were double stained with antibodies against tubulin and
constitutive AM or PAMP. In all cases, AM, PAMP, and
tubulin immunoreactivities overlapped on the microtubules
(Fig. 2, I–L).
Exposure of cells to cold temperatures (4 C) or to nocoda-
zole destabilizes their microtubules (22, 24). We hypothe-
sized that if AM and PAMP are associated with microtu-
bules, their cellular distribution must follow the same
dynamics. As an example, COS7 cells transfected with
pRed-AM lost the tubular aspect of the red fluorescence,
which is observed under standard conditions (Fig. 3, A–C),
when they were exposed to the cold (Fig. 3, D–F) or nocoda-
zole (Fig. 3, G–I).
Microtubule binding and polymerization assays
To ascertain whether AM and PAMP are true MAPs, a
microtubule spin-down assay was performed. AM did not
get spun down by tubulin, but PAMP was. As expected for
a MAP, the amount of PAMP in the supernatant fraction was
higher in the absence of microtubules than in its presence,
whereas the amount of peptide as detected by Western blot-
ting increased in the pellet fraction of preparations contain-
ing microtubules (Fig. 4A). Interestingly, in the presence of
microtubules, an immunoreactive band of about 60 kDa ap-
peared. This band was never detected in the absence of
microtubules or PAMP. Incubation with a set of MAPs re-
sulted in a slight reduction in the intensity of the 60-kDa
band, suggesting a competition between classical MAPs and
PAMP. Because tubulin monomers have a molecular mass of
55 kDa, this band may represent the association of tubulin
and PAMP.
To investigate whether AM and PAMP influence cytoskel-
eton function in vitro, microtubule polymerization assays in
the presence and absence of AM or PAMP were performed.
PAMP resulted in a significant delay in tubulin polymeriza-
tion, whereas taxol, used as a control, markedly increased
polymerization speed (Fig. 4B). This effect was observed
even at very low concentrations of PAMP (down to 1 nm).
Despite a large number of variations in the conditions of the
assay (different concentrations of peptide, addition of MAPs
to the tubulin preparation, increased concentrations of glyc-
erol, etc.), we never saw any change in tubulin polymeriza-
tion in the presence of AM (results not shown).
Identification of effective siRNA sequences for human AM
down-regulation
Using Ambion’s software tools, we selected five short se-
quences of the human proAM cDNA that complied with the
restrictions imposed by the algorithm. These were 19 nucle-
otide-long oligonucleotides beginning at positions 17, 253,
511, 735, and 950 of the human cDNA (GenBank accession no.
NM_01124). Double-stranded RNA containing these se-
quences was cotransfected into CHO cells together with plas-
mid pFLAG-AM, which overexpresses human AM mRNA.
PCR analysis of total RNA from these cells revealed a strong
TABLE 2. Proteins identified by yeast-2 hybrid with PAMP as the bait
No. of clones GenBank accession no. Name Function Refs.
2 NM_001069.2 Tubulin -2A Cytoskeleton component 67
2 BC031828.2 Kinesin heavy chain member 2 Motor protein 23
3 AF144237.1 LOMP protein, LIM domain 7, LMO7 Focal adhesion
4 NM_005680.1 TAF1B Transcription initiation
2 BC088371.1 EGF-like domain, variant 7 Notch4-like receptor
1 NM_000386.2 Bleomycin hydrolase
1 NM_004447.4 EPS8 EGF-R signaling
1 NM_014941.1 MORC2 Meiosis inhibitor
EGF, Epidermal growth factor; EGF-R, epidermal growth factor receptor.
TABLE 1. Proteins identified by yeast-2 hybrid with AM as the bait
No. of clones GenBank accession no. Name Function Refs.
3 NM_002373 MAP1A Regulates cytoskeleton in mature neurons 18
1 XM_056494 CKAP1 Tubulin folding factor 20
1 NM_005493 RANBP9 Centrosomal protein 21, 22
1 XM_045140 Prosaponin Lipid interaction
1 BC032626 TLH29 Cell cycle
1 AF_508964 NTRK2 Noncatalytic form of surface receptor
2 XM_165875 CDC2-related protein kinase 5 Cell cycle
1 BC032691 FLJ10715 Unknown
1 NM_006288 Thy-1 cell surface antigen Unknown
Sackett et al. • AM and PAMP Decorate Microtubules Endocrinology, June 2008, 149(6):2888–2898 2891
down-regulation of AM mRNA for all chosen sequences,
being more potent for oligonucleotides 511 and 735 (Fig. 5A).
These sequences were selected to generate siRNA expression
vectors capable of sustaining stable expression. The human
cell line A549 and the monkey cell line COS7 were stably
transfected with vectors containing the siRNA sequence or a
scrambled version as a negative control. We have shown that
the monkey proAM cDNA is almost identical to its human
counterpart (16), thus allowing the use of common reagents.
Real-time PCR analysis of proAM mRNA contents in the
transfected cells showed a decrease of 54% in both cell lines
with pSEC-AM735 (Fig. 5B), whereas pSEC-AM511 was less
potent in reducing proAM levels (31% reduction, results not
shown). To ensure that the decrease in mRNA was followed
by a parallel decrease in protein, Western blot analyses were
performed. In A549, a clear decrease in AM immunoreac-
tivity was observed in cells transfected with pSEC-AM735
compared with the scrambled sequence (Fig. 5C). The pep-
FIG. 3. Effects of microtubule destabilization on
intracellular distribution of AM. COS7 cells were
transfected with pRed-AM and exposed to control
conditions (A–C), cold (4 C for 30 min) (D–F), or
105 M nocodazole (G–I). Cells were counter-
stained with Bodipy-phallacidin. Bar, 5 m.
FIG. 2. AM and PAMP are associated
withmicrotubules. Triple-color confocal
microscopy of cell lines COS7 (A–H) and
H32 (I–L). The third column (C, G, and
K) shows nuclear counterstain with
DAPI, and the fourth column (D, H, and
L) is the combination of the previous
images, with yellow color representing
a complete overlapping of red and green
signals. In the first panel (A–D), COS7
cells were transfected with pRed-AM
(A) and stained with antibodies against
tubulin, detected with a green fluoro-
chrome (B). The second panel (E–H)
shows a double transfection with
pRed-AM (E) and pGreen-CKAP (F).
The third panel shows double immuno-
fluorescence for PAMP (I) and tubulin
(J). Bar, 10 m.
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tide contents of COS7 were below the detection limit of the
assay (Fig. 5C), so we performed a RIA for AM of the con-
ditioned media to ensure that a significant decrease was
taking place at the protein level (Fig. 5D).
Down-regulation of proAM expression changes cytoskeletal
morphology
The consequences of proAM silencing in microtubule mor-
phology and physiology were studied. The first change ob-
served was a modification in cell shape in A549 cells trans-
fected with the pSEC-AM735 vector. These cells showed a
more pleomorphic aspect than their control counterparts
transfected with the scrambled sequence, with long cell pro-
cesses that gave these cells a more “spiky” look (Fig. 6, A and
B). These changes were not so evident in COS7 cells (results
not shown). These and the following results were similar
when using either pSEC-AM735 or pSEC-AM511, although
differences with controls were stronger with the former vec-
tor. Only results obtained with pSEC-AM735 are presented
here for brevity sake.
When the stably transfected cells were labeled with an
antitubulin antibody and analyzed by confocal microscopy,
striking differences in cytoskeleton morphology were ob-
served. Cells transfected with the scrambled sequence pre-
sented microtubules indistinguishable from the ones found
in nontransfected cells. These microtubules were arranged in
a star-like pattern emanating from the centrosome and reach-
ing the cell periphery with a straight morphology (Fig. 6,
C–E). In sharp contrast, cells expressing the siRNA for
proAM had a higher number of microtubules, these were less
organized, and they formed arch-like structures in the pe-
riphery of the cells (Fig. 6, F–H). This morphological pattern
is similar to the one obtained with the administration of
microtubule-stabilizing drugs, such as taxol (25).
In stabilized microtubules several posttranslational mod-
ifications occur. These include partial proteolysis of the car-
boxy-terminal tyrosine that exposes a glutamic acid residue,
and acetylation at the amino end of the tubulin monomer (26,
27). Using a specific antibody against glu-tubulin, we found
that cells expressing siRNA for proAM (Fig. 6, L–N) were
more immunoreactive than the corresponding controls (Fig.
6, I–K), reinforcing the concept that proAM down-regulation
induces microtubule stabilization.
Because cells expressing siRNA for proAM have a mor-
phology consistent with microtubule hyperpolymerization,
we hypothesized that their microtubules should be more
resistant to cold than the ones in cells containing the scram-
bled sequence. After 30 min at 4 C, COS7 cells transfected
FIG. 4. Interactions of PAMP with tubulin as shown by spin down
assay (A) and by tubulin polymerization assay (B). Taxol-stabilized
microtubules (Tub) were incubated in the absence and presence of
synthetic PAMP (with amolecularmass of 3 kDa) and/ormicrotubule-
associated protein fraction (MAPF), centrifuged, and the supernatant
was separated from the pellet. Both fractions were analyzed byWest-
ern blotting with an antibody against PAMP (A). For the tubulin
polymerization assay (B), equal amounts of bovine brain tubulin in
the presence and absence of PAMP or taxol were incubated at 37 C
in 96-well plates, and the degree of polymerization was determined as
a direct correlate of the absorption at 340 nm over time. The blot (A)
and graph (B) are representative examples of three independent re-
peats. No add, No addition (control).
FIG. 5. A, Characterization of siRNAs for AM. Five double-stranded
RNA sequences were transiently cotransfected with pFLAG-AM into
CHO cells, and AM mRNA levels were analyzed by regular PCR. B,
The more efficient sequence (AM735) and a scrambled version of it
were cloned into pSEC, stable transfectants were generated in COS7
and A549 cells, and the AM mRNA levels in these transfected cells
were quantified by real-time PCR. C, Protein extracts from the same
cells were characterized byWestern blottingwith an antibody specific
to AM.D, The supernatant of COS7was also analyzed by RIA because
the levels of AM were undetectable by Western blotting.
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with pSEC-AMscr lost all of their microtubules (Fig. 6, O–Q),
whereas cells transfected with pSEC-AM735 still had recog-
nizable microtubular structures (Fig. 6, R–T).
To confirm that lower levels of proAM translate into a
higher number of microtubules, we also analyzed immor-
talized cell lines of embryo fibroblasts obtained from wild-
type and AM-heterozygous mice (Fig. 7). Wild-type cells
displayed the characteristic morphology of regular micro-
tubules (Fig. 7, A–D). In agreement with our AM knockdown
experimental data, cells obtained from heterozygous AM
embryos presented a much higher number of microtubules
with the typical arches below the plasma membrane (Fig. 7,
E–H).
Microtubule stabilization upon down-regulation of
proAM levels was confirmed by Western blot analysis in
COS7 cells. Immunoreactivity for two posttranslational mod-
ifications of tubulin related to microtubule stabilization
(acetylated tubulin and glu-tubulin) was much higher in cells
transfected with the siRNA for proAM than in the cells car-
rying the scrambled sequence (Fig. 8). The levels of total
-tubulin and GAPDH were the same between these two cell
lines.
Down-regulation of AM changes microtubule-mediated
functions
Microtubules are involved in a variety of cell behaviors,
including cell cycle and motility (28, 29). To investigate
whether proAM levels have an impact on microtubule-me-
diated functions, we analyzed these cell parameters in stably
transfected cells.
Cell cycle analysis of COS7 cells transfected with pSEC-
AM735 revealed a statistically significant G2 arrest and a
concomitant decrease in the S phase when compared with
cells transfected with the scrambled sequence (Table 3).
Cell migration was also examined with a chemotaxis as-
say. COS7 cells transfected with the siRNA cassette showed
less migration efficiency than the scrambled control (Fig. 9).
Discussion
In this report we show that intracellular AM and PAMP
decorate microtubules under both artificial and native con-
ditions, and that PAMP decreases tubulin polymerization in
vitro. In addition, proAM down-regulation by either siRNA
technology or gene targeting results in morphological
changes of the cytoskeleton and in modifications of micro-
tubule-mediated functions. Thus, we can identify PAMP as
a novel MAP involved in cytoskeleton homeostasis. Curi-
ously, AM failed to modify specific assays for microtubule
polymerization, indicating that AM is not a real MAP, al-
though it might exert some functions through interaction
with bona fide MAPs. We should point out that AM is well
conserved through evolution, whereas PAMP has experi-
enced wider sequence variations (30). It would be interesting
to study whether all PAMP molecules, derived from different
species, bind microtubules in the same fashion.
Several of the proteins that interact with AM and PAMP
in the yeast-2 hybrid system were identified in several clones,
confirming the strong interaction between both partners in-
side the yeasts.
FIG. 6. Morphological effects of transfection with AM siRNA. A549
cells transfected with pSEC-AMscr (A) or pSEC-AM735 (B) present
different morphological features under phase-contrast microscopy.
Bar, 20 m. Double-color confocal microscopy of COS7 cells (C–T)
stained with Bodipy-phallacidin (green, C, F, I, L, O, and R) and an
antibody against tubulin (D, G, P, and S) or glu-tubulin (J andM). The
third column (E, H, K, N, Q, and T) is the combination of the previous
images. Microtubules in COS7 cells transfected with pSEC-AMscr
(C–E) have the typical radial pattern of this cell line, whereas the
same cells transfected with pSEC-AM735 (F–H) contain more micro-
tubular structures that curve at the cell surface and return back into
the cell. When the same cells are stained with an antibody against
polymerized tubulin (glu-tubulin), cells transfected with pSEC-AM-
scr (I–K) have only a few labeled microtubules, but cells transfected
with pSEC-AM735 (L–N) display a complex system of curved micro-
tubules. After exposure of these cells to a cold environment (4 C for
30 min), microtubules were completely depolymerized in pSEC-AM-
scr transfected cells (O–Q), whereas pSEC-AM735 containing cells
maintained their cytoskeleton (R–T). Bar, 5 m.
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The core of the microtubules consists of a dynamic cylin-
drical polymer of tubulin. Microtubule dynamics involve the
addition and loss of tubulin dimers from the ends of the
microtubules through two different mechanisms: preferen-
tial addition at the “plus” end and loss at the “minus” end
in the process of treadmilling, and preferential addition and
loss at the plus end (compared with the minus end) in the
process of dynamic stability (28, 31–33). Both processes can
be active without altering the steady-state level of polymer-
ized tubulin. However, microtubules can be modulated by
MAPs, changes in tubulin isotypes, tubulin mutations, or
microtubule-active drugs (24, 34, 35). These changes may
alter the steady-state levels of polymerized tubulin as well as
altering posttranslational modifications of tubulin (36, 37).
The posttranslational modifications of tubulin that have been
associated with stable microtubules include detyrosination
of the carboxy terminus of -tubulin (revealing the penul-
timate glutamic acid residue, and, therefore, often referred to
as glu-tubulin), acetylation of lysine 40 in -tubulin, as well
as others (27, 38). These posttranslational changes have been
demonstrated in the cells expressing lower levels of proAM.
This observation is in agreement with the delay in tubulin
polymerization induced by PAMP.
Many MAPs have been described. These are proteins that
bind to the tubulin core and modulate the stability and/or
functions of the microtubules. Specific MAPs can act as cel-
lular motors (39, 40), tubulin-folding molecules (41), anchors
to other cellular structures (42), or modulators of microtubule
stability (43). The data presented in this report identify
PAMP as a novel MAP involved in regulating microtubule
assembly. In contrast, AM was identified as a peptide that
decorates the microtubules but does not influence tubulin
polymerization directly. Given that PAMP and AM are pro-
duced by the same gene, it is rather difficult to separate their
individual contribution to cytoskeleton homeostasis through
genetic techniques. The fact that PAMP is the only molecule
of the two capable of modifying tubulin polymerization sug-
gests a more relevant function for this peptide, but we cannot
exclude a more subtle regulatory role for AM, possibly
through interaction with other MAPs rather than directly on
microtubule stability.
Our results are in agreement with previous observations
that described the presence of AM immunoreactivity in areas
rich in microtubules such as the dendritic processes in neu-
rons (11) and the subciliary region in epithelial cells of the
lung (12). In fact, if we compare immunohistochemical im-
ages for AM (11) and MAP1A (44) in pyramidal neurons of
the rat brain, the patterns are identical. Our results also
correlate well with a recent gene expression profile study
comparing prostate tumor cells overexpressing AM with
their wild-type counterparts. Some of the proteins whose
expression was elevated in the cells with high levels of AM
were cytoskeleton-related molecules (45). Less information is
available for the distribution of PAMP, but both molecules
derive from the same gene, and similar expression patterns
are expected, although the existence of an alternative splicing
mechanism that changes the ratio of expression has been
described for this gene (46).
Genetic engineering to knockout or knockdown the gene
of interest has been widely used to investigate the physio-
logical contribution of particular gene products (47). Down-
regulation of proAM expression through siRNA technology
or gene targeting results in microtubule hyperpolymeriza-
tion, suggesting that AM and/or PAMP plays an important
role in maintaining microtubule physiology. The morphol-
ogy of the cytoskeleton in cells containing low levels of
proAM is similar to the one observed after treatment with
microtubule-stabilizing drugs such as taxol (48). This change
in microtubule morphology translated into a modification of
cell shape in A549 but not in COS7, indicating that cell mor-
phology may be regulated by more parameters than just
microtubule status. In addition, the cytoskeleton of cells with
less proAM was more resistant to the cold than the controls,
strengthening the concept that the lack of proAM induces
microtubule hyperpolymerization.
In addition to cell shape (49), a number of other cell fea-
tures require the intervention of the cytoskeleton, including
regulation of the cell cycle and cell migration (28, 29). During
the cell cycle, microtubules play a major role in mitosis in
which the mitotic spindle separates the homologous chro-
matids into the resulting daughter cells (50–52). Drugs that
TABLE 3. Cell cycle parameters in transfected COS7 cells as
measured by flow cytometry
G1 G2 S
COS7 pSEC-AMscr 57.2  1.0 11.9  0.8 31.0  0.3
COS7 pSEC-AM735 55.6  1.5 16.0  0.6 28.5  1.0
P value ns 0.002 0.01
Each point represents the mean and SD of three independent mea-
surements. ns, Not statistically significant.
FIG. 7. Differences in cytoskeleton
morphology between mouse embryo
fibroblasts obtained from wild-type
(A–D) and AM heterozygous (E–H) an-
imals. Cells were grown in slides and
stained with Bodipy-phallacidin (A and
E), antitubulin detected in red (B and
F), andDAPI (CandG). The last column
(D and H) represents a composite of the
previous images. Bar, 5 m.
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stabilize microtubules induce cell cycle arrest due to an in-
ability to depolymerize the mitotic spindle (53, 54), among
other effects. COS7 cells expressing lower proAM levels had
a statistically significant increase in the number of cells found
in G2. AM and PAMP have been previously identified as
growth factors (55–57), but those effects were attributed to a
paracrine/autocrine effect mediated through specific recep-
tors at the cell surface. Although we cannot completely ex-
clude the involvement of membrane receptors activated by
the peptides, our present results indicate that AM and/or
PAMP may also have an intracellular contribution to cell
growth regulation by allowing cells to pass through mitosis
unhindered. In a microarray analysis paper, Ma et al. (58)
present evidence showing that up-regulation of E2F1 (a pro-
tein expressed during the G1 and S phases of the cell cycle
and implicated in G1 to S transition) down-regulates AM
levels in mouse fibroblasts. These data would suggest a de-
crease of proAM levels during the G1 and S phases of the cell
cycle that, according to our results, may induce microtubule
polymerization in preparation for spindle assembly.
There is a link between microtubule polymerization status
and cell motility, but this relationship may be complex. For
instance, cells exposed to the microtubule-stabilizing agent
paclitaxel (taxol) migrate faster than untreated controls, but
when the same cells have been previously treated with ion-
izing radiation, paclitaxel-treated cells migrate at a slower
rate than the corresponding controls (59). When tumor cells
are treated with sublethal doses of paclitaxel, the surviving
clones display more efficient chemotaxis than the original
cells (60). On the other hand, microtubule hyperpolymer-
ization produces the loss of neutrophil chemotaxis, but not
random motility (61). We and others have shown that ex-
ternal addition of AM to cells in culture can result in either
enhancement (14, 62) or reduction (63) of cell motility, de-
pending on the cell type under scrutiny. In this study we
show that reduction of proAM expression levels in COS7
cells results in a decrease in migration. As with the cell cycle
regulation, we cannot exclude the fact that cells expressing
less proAM secrete less peptide to the medium, and, thus,
autocrine receptor activation would be lower.
In some animal models recapitulating human diseases,
microtubule hyperpolymerization has been reported. This is
the case of pressure-overload cardiac hypertrophy in which
the cytoskeleton displays a marked hyperstabilization in the
cardiomyocytes of treated cats (25). AM and PAMP have
been described as protective peptides against heart remod-
eling, hypertrophy, and other cardiac dysfunctions (64). It
would be interesting to investigate whether this protective
function is mediated, at least in part, through the
cytoskeleton.
Recent studies have shown that the phenotype of the
proAM gene knockouts are very similar to those of the AM
receptor CRLR/RAMP2 (65, 66), suggesting that circulating
AM but not PAMP exerts potential function. Nevertheless, it
has been shown that PAMP is a more potent angiogenic
factor than AM (17), and here, we show a specific function
for PAMP in cytoskeletal regulation. It may be that PAMP
acts in a more local environment, as an autocrine or paracrine
peptide (even at the intracellular level), whereas AM is more
of a classical endocrine peptide hormone. More careful stud-
ies of the available knockout models may shed more light on
this subject.
In conclusion, we have shown that AM and PAMP bind
microtubules and decorate the cytoskeleton in a variety of
cell types. PAMP reduces tubulin polymerization, whereas
AM does not have any effect in this assay. Down-regulation
of proAM results in cytoskeleton changes that modify cell
behavior. Recognizing the intracellular functions of AM
and/or PAMP may help to understand the impact of these
molecules in normal physiology and in the diseases in which
they seem to play a major role, such as cardiovascular and
cerebrovascular dysfunctions, cancer, and diabetes (1).
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